Meet the team

Transformative creativity, meaningful research and disruptive innovation typically do not come from doing what is comfortable or generally acceptable. This requires courage of thought and may involve some level of risk but in return can lead to significant improvements in our patients’ health and lives.

Search & Evaluation – Emerging Science

Scroll to read Biography

Dan Savyckyj covers Emerging Science opportunities, such as potential disruptive technologies, platforms, diagnostics or novel actives. Dan also supports direct investment efforts across relevant GSK areas of interest.  He brings extensive experience in investment analysis and portfolio management from previous positions at the International Finance Corporation – World Bank Group, Baring Asset Management and Evergreen Investments, as well as medical training at Jefferson Medical College, to his role. Dan holds a BA from the University of Pennsylvania and an MBA from Georgetown University.